Comparative thermo-stability of two Rift Valley fever virus vaccine candidate CL13T with a recombinant arMP-12ΔNSm21/384

por Daouam, S, Boumart, Z, Elarkam, A, Hamdi, J, Tadlaoui, KO, Ennaji, MM, harraka, MEL
Publicado 2020

In-vitro and in-vivo study of the interference between Rift Valley fever virus (clone 13) and Sheeppox/Lumpy Skin disease viruses

por Safini, N., Bamouh, Z., Hamdi, J., Jazouli, M., Tadlaoui, K. O., El Harrak, M.
Publicado 2021

Safety and immunogenicity of the Rift Valley fever arMP-12 ΔNSm21/384 candidate vaccine in pregnant ewes

por Boumart, Z., Bamouh, Z., Hamdi, J., Safini, N., Tadlaoui, K.O., Bettinger, G., Watts, D.M., Elharrak, M.
Publicado 2020